MA08.02 Outcomes of Early Stage ALK-positive NSCLC Patients in a Real-World Cohort

S. Schmid,S. Chotai,S. Cheng,L. Zhan,K. Balaratnam,K. Khan,D. Patel,M. C. Brown,W. Xu,P. Moriarty,O. Kaidanovich-Beilin,F. A. Shepherd,A. Sacher,N. Leighl,P. Bradbury, G. Liu

Journal of thoracic oncology（2021）

引用 1|浏览22

暂无评分

摘要

While there has been a series of real-world studies on ALK-positive non-small cell lung cancer (NSCLC) in the advanced/metastatic setting, there are far fewer reports about the outcome of early stage ALK-positive cancer. The aim of this analysis was to study treatment patterns and outcomes in a real-world cohort of patients with ALK+ NSCLC diagnosed in stages I-III.

查看译文

关键词

early stage,ALK,treatment and recurrence patterns

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要